Lotus Pharmaceutical Co., Ltd. research, develops, manufactures, and sells generic pharmaceutical products in Taiwan, Korea, the United States, and internationally. Its product portfolio focuses on generics in the fields of oncology, cardiology, nephrology, women's health, anti-obesity, and central nervous system disease. The company also sells and markets a portfolio of over-the-counter medicines. In addition, it engages in wholesale of cosmetics; retail of clinical machines; biotech technological consulting services; sale of pharmaceuticals and medicinal chemical; marketing activities; market planning and business information services; and consultancy services on health management, health technology, and trading information services. Further, the company offers pharmaceutical regulatory affairs project management, and data collection and agency services; healthcare consultancy services and operates as a contract research organization. Lotus Pharmaceutical Co., Ltd. was incorporated in 1966 and is headquartered in Taipei City, Taiwan. Lotus Pharmaceutical Co., Ltd. is a subsidiary of Alvogen Emerging Markets Holdings Limited.
Lotus Pharmaceutical Dividend Announcement
• Lotus Pharmaceutical announced a annually dividend of NT$4.65 per ordinary share which will be made payable on 2024-08-30. Ex dividend date: 2024-08-05
• Lotus Pharmaceutical annual dividend for 2024 was NT$4.65
• Lotus Pharmaceutical annual dividend for 2023 was NT$3.46
• Lotus Pharmaceutical's trailing twelve-month (TTM) dividend yield is 1.83%
• Lotus Pharmaceutical's payout ratio for the trailing twelve months (TTM) is 22.58%
Lotus Pharmaceutical Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-08-05 | NT$4.65 | annually | 2024-08-30 |
2023-07-05 | NT$3.46 | annually | 2023-08-01 |
2022-08-04 | NT$1.93 | annually | 2022-08-31 |
2021-07-07 | NT$0.35 | annually | 2021-08-03 |
2011-09-27 | NT$0.27 | annually | |
2010-09-08 | NT$0.09 | annually | |
2009-08-12 | NT$0.16 | annually | |
2008-08-14 | NT$0.75 | annually |
Lotus Pharmaceutical Dividend per year
Lotus Pharmaceutical Dividend growth
Lotus Pharmaceutical Dividend Yield
Lotus Pharmaceutical current trailing twelve-month (TTM) dividend yield is 1.83%. Interested in purchasing Lotus Pharmaceutical stock? Use our calculator to estimate your expected dividend yield:
Lotus Pharmaceutical Financial Ratios
Lotus Pharmaceutical Dividend FAQ
Other factors to consider when evaluating Lotus Pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Lotus Pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Lotus Pharmaceutical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Lotus Pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Lotus Pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Lotus Pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Lotus Pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Lotus Pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Lotus Pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Lotus Pharmaceutical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Lotus Pharmaceutical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.